BackRapport Therapeutics Overview
Rapport Therapeutics Inc.

Rapport Therapeutics Target Price

Analysts' 12-month price predictions for RAPP.

Get informed when a big investor buys or sells

+ Follow

Share Price

$38.88

Average Target Price

$58.5050.5% upside

4 analysts in the last 4 months

High: $66 | Low: $47

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-21BTIG$6567.2% upsideOpen
2026-05-18Truist Financial$5644% upsideOpen
2026-04-10Raymond JamesTiago Fauth$6669.8% upsideOpen
2026-03-09BTIGKambiz Yazdi$4720.9% upsideOpen
2026-02-02Wells FargoBenjamin Burnett$4310.6% upsideOpen
2025-12-19Wells Fargo$5131.2% upsideOpen
2025-12-09H.C. WainwrightDouglas Tsao$402.9% upsideOpen
2025-09-16Truist FinancialJoon Lee$4413.2% upsideOpen
2024-07-02JefferiesAndrew Tsai$3510% downsideOpen
2024-07-02Stifel NicolausPaul Matteis$3510% downsideOpen